Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.03 HKD | +0.67% |
|
+0.17% | -16.94% |
12/07 | CSPC Pharmaceutical Group's Respiratory Vaccine Gets NMPA's Nod for Clinical Trials | MT |
12/07 | China approves CSPC Pharma's RSV vaccine for clinical trials | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.94% | 9.06B | |
+55.35% | 848B | |
+31.64% | 627B | |
-0.10% | 363B | |
+15.47% | 318B | |
+13.10% | 299B | |
+15.51% | 243B | |
+16.72% | 225B | |
+16.54% | 179B | |
+4.31% | 167B |
- Stock Market
- Equities
- 1093 Stock
- News CSPC Pharmaceutical Group Ltd.
- CSPC Pharmaceutical Group Limited Appoints Wang Qingxi as Executive Director